Fierce competition to be seen for erectile dysfunction drugs
Published: 2011-12-23 07:00:00
Updated: 2011-12-23 07:00:00
With Korea’s third erectile dysfunction drug emerging in the market in October, other local companies are hoping U.S.-based Pfizer proves powerless to resist the stiffer competition as its Viagra patent is due to expire in next May.
JW Pharmaceutical unveiled the locally developed Zepeed two m...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
